Driving developments in UK oesophageal radiotherapy through the SCOPE trials.

ABSTRACT:

Background

The SCOPE trials (SCOPE 1, NeoSCOPE and SCOPE 2) have been the backbone of oesophageal RT trials in the UK. Many changes in oesophageal RT techniques have taken place in this time. The SCOPE trials have, in addition to adopting these new techniques, been influential in aiding centres with their implementation. We discuss the progress made through the SCOPE trials and include details of a questionnaire sent to participating centres. to establish the role that trial participation played in RT changes in their centre.

Methods

Questionnaires were sent to 47 centres, 27 were returned.

Results

100% of centres stated their departmental protocol for TVD was based on the relevant SCOPE trial protocol. 4DCT use has increased from 42 to 71%. Type B planning algorithms

SUBMITTER: Gwynne S 

PROVIDER: S-EPMC6360789 | biostudies-literature | 2019 Feb

REPOSITORIES: biostudies-literature